Crude and crystalline botulinum toxin type A have been compared for their ability to inhibit [ 14 C]ACh release from synaptosomes preloaded with [ 14 C]choline. The toxin preparations exhibited similar dose‐response curves, with maximal inhibition at 10 5 mouse LD 50 /ml after 60 min preincubation. The time course for the inhibitory action of the toxin showed that inhibition develops almost linearly over this time period. However, free toxin could be removed from the synaptosome suspension after 15 min without altering the subsequent development of inhibition of [ 14 C]ACh release, which suggests that the toxin is rapidly fixed by synaptosomes and that fixation alone cannot account for the latency of its action. Incorporation of gangliosides into synaptosomes by prior preincubation failed to increase the potency of the toxin, which implies that gangliosides do not serve as the membrane receptor for the toxin. Treatment of botulinum toxin with dithiothreitol greatly diminished its ability to inhibit [ 14 C]ACh release and it is suggested that botulinum toxin may be analogous to other bacterial toxins in its structure and mode of action.
No takes yet. Share an insight, caveat, or question.
Susan Wonnacott (1980) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: